Form 4: Director Thomas Kosasa Increases Stake in OneMedNet

Director Thomas Kosasa acquired 268,817 shares of OneMedNet Corp for $250,000 via a subscription agreement.

Summary

• Director Thomas Kosasa purchased 268,817 shares of OneMedNet Corp (ONMD) common stock.
• The transaction occurred on May 18, 2026, at a price of $0.93 per share.
• The total investment amount was $250,000.
• Following this transaction, the reporting person's total beneficial ownership increased to 16,930,144 shares.

Sentiment

Score: 7

Explanation: StockSavvy.ai views this as a positive signal, as insider buying by a major shareholder typically indicates confidence in the company's future prospects.

Positives

• Insider confidence is demonstrated by a significant $250,000 capital injection from a Director and 10% owner.
• The purchase price was determined by a 10-day volume-weighted average price (VWAP), ensuring market-aligned valuation.

Negatives

• None identified in this filing.

Risks

• Concentration of ownership by a single director may influence corporate governance decisions.
• Reliance on private subscription agreements for capital may indicate limited access to broader public equity markets.

Future Outlook

The filing does not provide forward-looking guidance regarding company operations, but confirms the execution of a subscription agreement for capital.

Management Comments

• The transaction was executed pursuant to a subscription agreement for a $250,000 investment in the issuer.

Industry Context

StockSavvy.ai notes that insider buying, particularly from 10% owners, is generally viewed as a positive signal of management's belief in the company's long-term valuation, especially in the small-cap healthcare technology sector.

Comparison to Industry Standards

• Insider purchases of this magnitude are common in small-cap growth companies to signal stability to the market.
• The use of a 10-day VWAP for pricing is a standard mechanism to mitigate volatility in thinly traded stocks.

Related Party Transactions

• The reporting person is a Director and 10% owner of the issuer.

Stakeholder Impact

• Shareholders may view the increased insider stake as a sign of commitment and stability.

Next Steps

• Monitoring of future SEC filings for additional insider activity or changes in ownership structure.

Key Dates

Recommendation

While insider buying is a positive indicator, a single transaction does not fundamentally change the investment thesis without broader financial performance data.

Keywords

OneMedNet, ONMD, Insider Trading, Form 4, Equity Investment, Thomas Kosasa